(Q35636401)

9 August 2017

1 reference

title

Effects of angiotensin converting enzyme inhibitors on thrombotic mediators: potential clinical implications (English)

1 reference

9 August 2017

Seema A Kothari

1

1 reference

9 August 2017

Mytrang K Le

series ordinal

2

1 reference

9 August 2017

Pritesh J Gandhi

series ordinal

3

1 reference

9 August 2017

publication date

1 June 2003

1 reference

Journal of Thrombosis and Thrombolysis

9 August 2017

published in

1 reference

9 August 2017

volume

15

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

217-225

1 reference

https://scigraph.springernature.com/pub.10.1023/b:thro.0000011379.68077.64

9 August 2017

exact match

0 references

cites work

Effects of enalapril on tissue factor in patients with uncomplicated acute myocardial infarction

1 reference

12 December 2020

Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction

1 reference

12 December 2020

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

1 reference

12 December 2020

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial

1 reference

12 December 2020

Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study)

1 reference

12 December 2020

Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.

1 reference

12 December 2020

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

12 December 2020

Vascular wall renin-angiotensin pathway in control of the circulation. A hypothesis.

1 reference

12 December 2020

GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico

1 reference

12 December 2020

Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina

1 reference

12 December 2020

Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina

1 reference

12 December 2020

Structural biology of tissue factor, the initiator of thrombogenesis in vivo

1 reference

12 December 2020

Expression of Renin-Angiotensin System Components in the Heart, Kidneys, and Lungs of Rats With Experimental Heart Failure

1 reference

12 December 2020

Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells

1 reference

12 December 2020

Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin

1 reference

12 December 2020

Angiotensin induces inflammatory activation of human vascular smooth muscle cells

1 reference

12 December 2020

Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

1 reference

12 December 2020

Increased cardiac angiotensin-converting enzyme in rats with chronic heart failure

1 reference

12 December 2020

Effect of enalapril and quinapril on forearm vascular ACE in man.

1 reference

12 December 2020

Fibrinolytic balance, the renin-angiotensin system and atherosclerotic disease

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis

1 reference

12 December 2020

1 reference

12 December 2020

Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells

1 reference

12 December 2020

Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages

1 reference

12 December 2020

Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats

1 reference

12 December 2020

Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus

1 reference

12 December 2020

The tissue factor pathway of blood coagulation

1 reference

12 December 2020

The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog.

1 reference

12 December 2020

ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collabor

1 reference

12 December 2020

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

Comparison of plasma tissue factor levels in unstable and stable angina pectoris.

1 reference

12 December 2020

Is the A1166C polymorphism of the angiotensin II type 1 receptor involved in cardiovascular disease?

1 reference

12 December 2020

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

12 December 2020

Angiotensin-Converting Enzyme Inhibitors Downregulate Tissue Factor Synthesis in Monocytes

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

12 December 2020

Plasminogen activator expression in human atherosclerotic lesions

1 reference

12 December 2020

Cellular distribution of angiotensin-converting enzyme after myocardial infarction

1 reference

12 December 2020

Monocyte tissue factor-like activity in post myocardial infarction patients

1 reference

12 December 2020

Increased thrombogenic potential of human monocyte-derived macrophages spontaneously transformed into foam cells.

1 reference

12 December 2020

Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells

1 reference

12 December 2020

Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1)

1 reference

12 December 2020

Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin

1 reference

12 December 2020

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

12 December 2020

Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction

1 reference

12 December 2020

Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. On behalf of the Subcommittee on Tissue factor Pathway Inhibitor (TFPI) of the Scientific and Standardization Committee of the

1 reference

12 December 2020

Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases

1 reference

12 December 2020

[Effect of infarct size and site, patency of the infarct vessel and perfusion of vital myocardium on remodeling of the left ventricle--studies with cine-magnetic resonance tomography in the first 6 months following myocardial infarct]

1 reference

12 December 2020

Captopril reduced plasminogen activator inhibitor activity in patients with acute myocardial infarction

1 reference

12 December 2020

Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality

1 reference

12 December 2020

Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts

1 reference

12 December 2020

Inhibition of factor X activation at extracellular matrix of fibroblasts during flow conditions: a comparison between tissue factor pathway inhibitor and inactive factor VIIa

1 reference

12 December 2020

Ramipril prevents endothelial dysfunction induced by oxidized low-density lipoproteins: a bradykinin-dependent mechanism

1 reference

12 December 2020

The renin-angiotensin system and fibrinolysis

1 reference

12 December 2020

Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure

1 reference

12 December 2020

A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans

1 reference

12 December 2020

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction

1 reference

12 December 2020

10.1023/B:THRO.0000011379.68077.64

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

1038021558

0 references

1 reference